Drug development is inherently uncertain, with scientific discoveries, manufacturing challenges, regulatory expectations and commercial priorities ...
Prescription Drug User Fee Act target action date is February 12, 2027 If approved, tinlarebant would be the first-ever approved treatment for Stargar...
Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, announced multiple U.S. Food and Drug Adm...
Revvity’s new maternal and fetal biochemistry testing platform Designed for accessibility, simplicity, and flexibility Purpose-built for small...
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, announced the upcoming availability of SPRQ-Nx chemistry and...
The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) announced the recipients of the 2026 Stephenson Global Scholar Grants. In partnership...
QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour...
Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 m...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. announced that they have agreed to update their long-term relat...
Award supports an iPSC and AI-driven drug discovery program targeting the leading cause of death in DMD patients Greenstone Biosciences, a biote...
The U.S. Food and Drug Administration granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral t...
Biogen Inc. announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing sm...
MVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virus A...
Bone Biologics is developing a targeted approach to bone regeneration through its proprietary NELL-1 platform, designed to address the li...
© 2026 Biopharma Boardroom. All Rights Reserved.
